RETREG1 and neoplasm: Mutation in the majority of metastatic lymph node tissues compared to primary tumours (Table 3) indicates that FAM134B (JK1) mutation may offer a survival advantage in different tumour microenvironments, or assist in colonisation of those particular microenvironments.